No Data
12 Health Care Stocks Moving In Friday's After-Market Session
Nexalin Technology Plans To Submit Q-Submission To FDA Related To Gen-2 SYNC System
Express News | Nexalin Technology Initiates FDA Q-Submission Process for Gen-2 Sync Following Encouraging Data and Preliminary FDA Feedback
Nexalin Technology Initiates FDA Q-Submission Process for Gen-2 SYNC Following Encouraging Data and Preliminary FDA Feedback
Express News | Nexalin Technology Receives Irb Approval in Brazil and Begins Clinical Trial for Anxiety and Insomnia
Nexalin Technology Receives IRB Approval in Brazil and Begins Clinical Trial for Anxiety and Insomnia
